U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 353

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr7:117144360
GRCh38:
Chr7:117504306
CFTRD36ACongenital bilateral aplasia of vas deferens from CFTR mutationUncertain significancecriteria provided, single submitter
2.
GRCh37:
Chr7:117120192
GRCh38:
Chr7:117480138
CFTRL15HCongenital bilateral aplasia of vas deferens from CFTR mutationLikely pathogenic
(Nov 15, 2021)
criteria provided, single submitter
3.
GRCh37:
Chr7:117188854
GRCh38:
Chr7:117548800
CFTR, CFTR-AS1A457TCongenital bilateral aplasia of vas deferens from CFTR mutationUncertain significance
(Jul 8, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr7:117232046
GRCh38:
Chr7:117591992
CFTRH609YCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutationLikely pathogenic
(Apr 20, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr7:117171137
GRCh38:
Chr7:117531083
CFTRR153KCystic fibrosis, Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis, Spermatogenic failure, Y-linked, 2
Conflicting interpretations of pathogenicity
(Sep 5, 2022)
criteria provided, conflicting interpretations
6.
GRCh37:
Chr7:117232334
GRCh38:
Chr7:117592280
CFTRI705VBronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis, Hereditary pancreatitis,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Uncertain significance
(Feb 17, 2023)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr7:117282620
Chr7:117282622
GRCh38:
Chr7:117642566
Chr7:117642568
CFTR, CFTRW1282*, R1283MCystic fibrosisPathogenic
(Jan 10, 2020)
reviewed by expert panel
8.
GRCh37:
Chr7:117175368
GRCh38:
Chr7:117535314
CFTRW216RCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutationUncertain significance
(Jul 22, 2021)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr7:117149107
GRCh38:
Chr7:117509053
CFTR, LOC113664106A62TCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutationUncertain significance
(Jul 22, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr7:117175404
GRCh38:
Chr7:117535350
CFTRG228CCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutationUncertain significance
(Jul 22, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr7:117175315
GRCh38:
Chr7:117535261
CFTRA198Vnot specified, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Uncertain significance
(Jan 9, 2023)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr7:117171115
GRCh38:
Chr7:117531061
CFTRH146YCFTR-related condition, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Uncertain significance
(Aug 21, 2023)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr7:117188682
GRCh38:
Chr7:117548628
CFTR, CFTR-AS1not specified, not provided, Cystic fibrosis,
Bronchiectasis with or without elevated sweat chloride 1, Hereditary pancreatitis, Cystic fibrosis,
Congenital bilateral aplasia of vas deferens from CFTR mutation
Benign/Likely benign
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr7:117174305
GRCh38:
Chr7:117534251
CFTRCongenital bilateral aplasia of vas deferens from CFTR mutationUncertain significance
(Sep 2, 2019)
criteria provided, single submitter
15.
GRCh37:
Chr7:117171068
GRCh38:
Chr7:117531014
CFTRL130PCongenital bilateral aplasia of vas deferens from CFTR mutation, not providedUncertain significance
(Sep 9, 2021)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr7:117282582
Chr7:117149143
GRCh38:
Chr7:117642528
Chr7:117509089
CFTR, CFTRD1270N, R74Wnot specifiedUncertain significance
(Oct 6, 2023)
criteria provided, single submitter
17.
GRCh37:
Chr7:117144323
GRCh38:
Chr7:117504269
CFTRL24VBronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation, Hereditary pancreatitis,
Cystic fibrosis, not provided, Cystic fibrosis
Uncertain significance
(Sep 9, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr7:117188704
GRCh38:
Chr7:117548650
CFTR, CFTR-AS1E407KCystic fibrosis, Cystic fibrosis, Hereditary pancreatitis,
Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation, not specified
Uncertain significance
(Aug 25, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr7:117230454
Chr7:117232223
GRCh38:
Chr7:117590400
Chr7:117592169
CFTR, CFTRG576A, R668Cnot specifiedLikely benign
(Apr 7, 2023)
criteria provided, single submitter
20.
GRCh37:
Chr7:117307644
GRCh38:
Chr7:117667590
CFTRBronchiectasis with or without elevated sweat chloride 1, Hereditary pancreatitis, Cystic fibrosis,
Congenital bilateral aplasia of vas deferens from CFTR mutation, CFTR-related disorders
Uncertain significance
(Sep 3, 2021)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr7:117227810
GRCh38:
Chr7:117587756
CFTR, LOC111674475CFTR-related disorders, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Conflicting interpretations of pathogenicity
(May 17, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr7:117230454
Chr7:117232223
Chr7:117188812
GRCh38:
Chr7:117590400
Chr7:117592169
Chr7:117548758
CFTR, CFTR, CFTR, CFTR-AS1G576A, R668C, D443YCystic fibrosisPathogenic
(Feb 25, 2020)
criteria provided, single submitter
23.
GRCh37:
Chr7:117251798
GRCh38:
Chr7:117611744
LOC111674472, CFTRM1101ICystic fibrosis, Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Uncertain significance
(Oct 10, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr7:117292956
GRCh38:
Chr7:117652902
CFTRD1312YCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, Bronchiectasis with or without elevated sweat chloride 1,
Hereditary pancreatitis, Cystic fibrosis
Uncertain significance
(Sep 29, 2021)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr7:117232374
GRCh38:
Chr7:117592320
CFTRP718RCongenital bilateral aplasia of vas deferens from CFTR mutation, Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis,
Hereditary pancreatitis, not specified, Cystic fibrosis
Uncertain significance
(Mar 14, 2023)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr7:117188680
GRCh38:
Chr7:117548626
CFTR, CFTR-AS1Congenital bilateral aplasia of vas deferens from CFTR mutation, Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis,
Hereditary pancreatitis, Cystic fibrosis
Likely benign
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr7:117188660-117188661
Chr7:117188683-117188686
GRCh38:
Chr7:117548606-117548607
Chr7:117548629-117548632
CFTR, CFTR-AS1, CFTR, CFTR-AS1Cystic fibrosisPathogenic
(Jan 29, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr7:117282570
GRCh38:
Chr7:117642516
CFTRE1266*Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Pathogenic/Likely pathogenic
(Jun 7, 2023)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr7:117232140-117232141
GRCh38:
Chr7:117592086-117592087
CFTRS641fsCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Pathogenic/Likely pathogenic
(Dec 7, 2020)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr7:117149176
GRCh38:
Chr7:117509122
CFTRG85*Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Pathogenic/Likely pathogenic
(Mar 31, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr7:117149098-117149099
GRCh38:
Chr7:117509044-117509045
LOC113664106, CFTRE60fsCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutationLikely pathogeniccriteria provided, single submitter
32.
GRCh37:
Chr7:117144380
GRCh38:
Chr7:117504326
CFTRV43ICFTR-related disorders, not specified, Bronchiectasis with or without elevated sweat chloride 1,
Hereditary pancreatitis, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis
Uncertain significance
(Jun 16, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr7:117243612
GRCh38:
Chr7:117603558
CFTRS895Tnot specified, not provided, CFTR-related disorders,
Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis, Hereditary pancreatitis,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Uncertain significance
(Nov 10, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr7:117251814
GRCh38:
Chr7:117611760
LOC111674472, CFTRF1107LCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, not provided,
Cystic fibrosis
Conflicting interpretations of pathogenicity
(Aug 27, 2021)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr7:117199643
GRCh38:
Chr7:117559589
CFTR-AS1, CFTRCongenital bilateral aplasia of vas deferens from CFTR mutation, not provided, Cystic fibrosis
Conflicting interpretations of pathogenicity
(May 26, 2022)
criteria provided, conflicting interpretations
36.
GRCh37:
ChrX:19023747-19024342
GRCh38:
ChrX:19005629-19006224
ADGRG2Congenital bilateral aplasia of vas deferens from CFTR mutationPathogenic
(Jul 8, 2019)
criteria provided, single submitter
37.
GRCh37:
ChrX:19031890
GRCh38:
ChrX:19013772
ADGRG2P300fs, P308fs, P314fs, P316fs, P322fs, P324fs, P335fs, P338fsCongenital bilateral aplasia of vas deferens from CFTR mutationPathogenic
(Sep 1, 2017)
criteria provided, single submitter
38.
GRCh37:
ChrX:19026204
GRCh38:
ChrX:19008086
ADGRG2G449fs, G457fs, G463fs, G465fs, G471fs, G473fs, G484fs, G487fsCongenital bilateral aplasia of vas deferens from CFTR mutationPathogenic
(Sep 1, 2017)
criteria provided, single submitter
39.
GRCh37:
ChrX:19054071
GRCh38:
ChrX:19035953
ADGRG2S60*, S68*, S76*, S81*, S84*Congenital bilateral aplasia of vas deferens from CFTR mutationPathogenic
(Sep 1, 2017)
criteria provided, single submitter
40.
GRCh37:
ChrX:19021097-19021098
GRCh38:
ChrX:19002979-19002980
ADGRG2F662fs, F684fs, F676fs, F670fs, F678fs, F700fs, F686fs, F697fsCongenital bilateral aplasia of vas deferens from CFTR mutationPathogenic
(Sep 1, 2017)
criteria provided, single submitter
41.
GRCh37:
ChrX:19017255
GRCh38:
ChrX:18999137
ADGRG2R787*, R795*, R801*, R803*, R809*, R811*, R822*, R825*Congenital bilateral aplasia of vas deferens from CFTR mutationPathogenic
(Sep 1, 2017)
criteria provided, single submitter
42.
GRCh37:
Chr7:117235055-117235056
GRCh38:
Chr7:117595001-117595002
CFTRV855ICystic fibrosis, not provided, Cystic fibrosis,
Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation
Conflicting interpretations of pathogenicity
(Aug 9, 2022)
criteria provided, conflicting interpretations
43.
GRCh37:
Chr7:117199645-117199647
Chr7:117250664
GRCh38:
Chr7:117559591-117559593
Chr7:117610610
CFTR, CFTR-AS1, CFTR, LOC111674472Cystic fibrosisPathogenic
(Mar 11, 2019)
reviewed by expert panel
44.
GRCh37:
Chr7:117199522
Chr7:117251704
GRCh38:
Chr7:117559468
Chr7:117611650
CFTR, CFTR-AS1, CFTR, LOC111674472S466*, R1070QCystic fibrosisPathogenic
(Mar 11, 2019)
reviewed by expert panel
45.
GRCh37:
Chr7:117174330
GRCh38:
Chr7:117534276
CFTRT164Anot specified, CFTR-related disorders, not provided,
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1, Hereditary pancreatitis,
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation
Uncertain significance
(Aug 18, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr7:117230451
GRCh38:
Chr7:117590397
CFTRF575YCongenital bilateral aplasia of vas deferens from CFTR mutation, not provided, Cystic fibrosis
Conflicting interpretations of pathogenicity
(Oct 7, 2022)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr7:117250691
GRCh38:
Chr7:117610637
CFTR, LOC111674472T1036ICystic fibrosis, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation
Conflicting interpretations of pathogenicity
(May 30, 2023)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr7:117188786
GRCh38:
Chr7:117548732
CFTR, CFTR-AS1S434*Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis, Cystic fibrosis
Pathogenic
(Jun 22, 2023)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr7:117251789
GRCh38:
Chr7:117611735
CFTR, LOC111674472W1098CCystic fibrosisPathogenic
(Aug 31, 2018)
reviewed by expert panel
50.
GRCh37:
Chr7:117267817
GRCh38:
Chr7:117627763
CFTRG1237DCongenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis, Hereditary pancreatitis,
Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis, not provided
Uncertain significance
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr7:117227824
GRCh38:
Chr7:117587770
CFTR, LOC111674475I539Tnot provided, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis,
Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis,
not specified
Uncertain significance
(Aug 29, 2023)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr7:117243784
GRCh38:
Chr7:117603730
CFTRM952ICongenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis, not provided
Conflicting interpretations of pathogenicity
(Jul 25, 2023)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr7:117171255
GRCh38:
Chr7:117531201
CFTRnot provided, Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1,
Hereditary pancreatitis, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation
Conflicting interpretations of pathogenicity
(Sep 12, 2022)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr7:117144390
GRCh38:
Chr7:117504336
CFTRA46Vnot provided, not specified, Cystic fibrosis,
Congenital bilateral aplasia of vas deferens from CFTR mutation
Conflicting interpretations of pathogenicity
(Aug 8, 2022)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr7:117232575
GRCh38:
Chr7:117592521
CFTRR785Qnot specified, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1, Hereditary pancreatitis
Uncertain significance
(Apr 21, 2023)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr7:117180209
GRCh38:
Chr7:117540155
CFTRA309Tnot provided, Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis, Hereditary pancreatitis, Cystic fibrosis,
not specified
Uncertain significance
(May 8, 2023)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr7:117242887
GRCh38:
Chr7:117602833
CFTRA876Vnot specified, Hereditary pancreatitis, Cystic fibrosis,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis
Uncertain significance
(May 19, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr7:117307016
GRCh38:
Chr7:117666962
CFTR, LOC111674477E1433*Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Pathogenic/Likely pathogenic
(Jul 21, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr7:117242901-117242902
GRCh38:
Chr7:117602847-117602848
CFTRW882fsCystic fibrosis, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation
Pathogenic/Likely pathogenic
(Mar 17, 2023)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr7:117230495
GRCh38:
Chr7:117590441
CFTRnot provided, Hereditary pancreatitis, Cystic fibrosis,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis
Pathogenic/Likely pathogenic
(Jun 15, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr7:117243750
GRCh38:
Chr7:117603696
CFTRL941fsCystic fibrosisPathogenic
(Sep 24, 2021)
reviewed by expert panel
62.
GRCh37:
Chr7:117267592
GRCh38:
Chr7:117627538
CFTRR1162Qnot provided, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Bronchiectasis with or without elevated sweat chloride 1, Hereditary pancreatitis, Cystic fibrosis,
not specified
Uncertain significance
(Apr 13, 2023)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr7:117180153
GRCh38:
Chr7:117540099
CFTRCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Pathogenic/Likely pathogenic
(Nov 8, 2017)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr7:117144345
GRCh38:
Chr7:117504291
CFTRR31Hnot specified, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis,
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1, Hereditary pancreatitis,
Congenital bilateral aplasia of vas deferens from CFTR mutation
Uncertain significance
(May 12, 2023)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr7:117306960
GRCh38:
Chr7:117666906
CFTR, LOC111674477Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Pathogenic/Likely pathogenic
(Sep 18, 2023)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr7:117199705
GRCh38:
Chr7:117559651
CFTR-AS1, CFTRE527Gnot specified, Cystic fibrosis, Cystic fibrosis,
Congenital bilateral aplasia of vas deferens from CFTR mutation
Conflicting interpretations of pathogenicity
(Jan 27, 2023)
criteria provided, conflicting interpretations
67.
GRCh37:
Chr7:117292899
GRCh38:
Chr7:117652845
CFTRV1293Inot specified, Cystic fibrosis, Cystic fibrosis,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1
Uncertain significance
(Oct 2, 2023)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr7:117254679
GRCh38:
Chr7:117614625
CFTRG1127EBronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis, Hereditary pancreatitis,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis, not specified
Uncertain significance
(Jun 5, 2023)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr7:117232171
GRCh38:
Chr7:117592117
CFTRF650LCystic fibrosis, Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1,
Hereditary pancreatitis, Congenital bilateral aplasia of vas deferens from CFTR mutation
Uncertain significance
(Feb 6, 2023)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr7:117304809
GRCh38:
Chr7:117664755
CFTRC1344SCystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, Bronchiectasis with or without elevated sweat chloride 1,
Hereditary pancreatitis, Cystic fibrosis, not specified
Uncertain significance
(May 24, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr7:117254773
GRCh38:
Chr7:117614719
CFTRCystic fibrosis, not specified, Cystic fibrosis,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1
Uncertain significance
(Oct 2, 2023)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr7:117199707
GRCh38:
Chr7:117559653
CFTR, CFTR-AS1E528Knot provided, Hereditary pancreatitis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1, CFTR-related condition,
Cystic fibrosis
Uncertain significance
(Aug 24, 2023)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr7:117171095
GRCh38:
Chr7:117531041
CFTRH139Pnot provided, Cystic fibrosis, Hereditary pancreatitis,
Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr7:117267624
GRCh38:
Chr7:117627570
CFTRG1173SCongenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1,
Hereditary pancreatitis, not provided, Cystic fibrosis
Conflicting interpretations of pathogenicity
(Aug 23, 2022)
criteria provided, conflicting interpretations
75.
GRCh37:
Chr7:117174411
GRCh38:
Chr7:117534357
CFTRF191VCystic fibrosisPathogenic
(Jan 10, 2020)
reviewed by expert panel
76.
GRCh37:
Chr7:117120189
GRCh38:
Chr7:117480135
CFTRK14Inot provided, not specified, Cystic fibrosis,
Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis
Uncertain significance
(Apr 14, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr7:117251769
GRCh38:
Chr7:117611715
CFTR, LOC111674472Y1092Hnot specified, CFTR-related condition, not provided,
Cystic fibrosis, Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Uncertain significance
(May 8, 2023)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr7:117120179
GRCh38:
Chr7:117480125
CFTRV11Inot specified, not provided, Cystic fibrosis,
Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Hereditary pancreatitis, Cystic fibrosis
Uncertain significance
(Aug 28, 2023)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr7:117251646
GRCh38:
Chr7:117611592
CFTR, LOC111674472I1051Vnot specified, CFTR-related disorders, Cystic fibrosis,
Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis
Uncertain significance
(Mar 21, 2023)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr7:117246795
GRCh38:
Chr7:117606741
CFTRF992Lnot provided, Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Hereditary pancreatitis, Cystic fibrosis
Uncertain significance
(Sep 22, 2021)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr7:117246757
GRCh38:
Chr7:117606703
CFTRI980Vnot provided, Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Hereditary pancreatitis, Cystic fibrosis
Uncertain significance
(Dec 21, 2021)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr7:117243734
GRCh38:
Chr7:117603680
CFTRP936Tnot provided, Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Hereditary pancreatitis, Cystic fibrosis
Uncertain significance
(Oct 18, 2021)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr7:117232155
GRCh38:
Chr7:117592101
CFTRM645Knot specified, Cystic fibrosis, Hereditary pancreatitis,
Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Uncertain significance
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr7:117199519
GRCh38:
Chr7:117559465
CFTR, CFTR-AS1T465Nnot provided, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis
Conflicting interpretations of pathogenicity
(May 1, 2023)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr7:117182140
GRCh38:
Chr7:117542086
CFTRN396Tnot provided, Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Hereditary pancreatitis, Cystic fibrosis
Uncertain significance
(Sep 5, 2021)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr7:117182116
GRCh38:
Chr7:117542062
CFTRT388Mnot specified, CFTR-related disorders, not provided,
Cystic fibrosis, Hereditary pancreatitis, Bronchiectasis with or without elevated sweat chloride 1,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Hereditary pancreatitis, Cystic fibrosis
Uncertain significance
(Jun 19, 2023)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr7:117182094
GRCh38:
Chr7:117542040
CFTRK381*Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis, Cystic fibrosis
Pathogenic/Likely pathogenic
(Oct 2, 2017)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr7:117182104-117182105
GRCh38:
Chr7:117542050-117542051
CFTRN386fsCystic fibrosisPathogenic
(Mar 17, 2017)
reviewed by expert panel
89.
GRCh37:
Chr7:117174348
GRCh38:
Chr7:117534294
CFTRR170CCystic fibrosis, Hereditary pancreatitis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Bronchiectasis with or without elevated sweat chloride 1, not provided, Hereditary pancreatitis,
not specified, Cystic fibrosis
Uncertain significance
(Jul 14, 2023)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr7:117243740
GRCh38:
Chr7:117603686
CFTRV938LCongenital bilateral aplasia of vas deferens from CFTR mutation, Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis,
Hereditary pancreatitis, Cystic fibrosis, not provided
Uncertain significance
(Apr 14, 2023)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr7:117232671
GRCh38:
Chr7:117592617
CFTRG817Vnot specified, Cystic fibrosis, Hereditary pancreatitis,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis
Uncertain significance
(Jul 5, 2023)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr7:117267757
GRCh38:
Chr7:117627703
CFTRA1217VBronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Hereditary pancreatitis, not specified, not provided,
Cystic fibrosis
Uncertain significance
(Feb 10, 2023)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr7:117199562
GRCh38:
Chr7:117559508
CFTR, CFTR-AS1E479Dnot specified, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Bronchiectasis with or without elevated sweat chloride 1, Hereditary pancreatitis, CFTR-related condition,
not provided, Cystic fibrosis
Uncertain significance
(Aug 28, 2023)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr7:117243733-117243738
GRCh38:
Chr7:117603679-117603684
CFTRnot provided, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis,
Cystic fibrosis
Pathogenic/Likely pathogenic
(Sep 5, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr7:117199593
GRCh38:
Chr7:117559539
CFTR, CFTR-AS1F490fsnot provided, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis
Pathogenic/Likely pathogenic
(Aug 24, 2023)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr7:117227896
GRCh38:
Chr7:117587842
CFTR, LOC111674475not provided, Congenital bilateral aplasia of vas deferens from CFTR mutation, not specified,
Cystic fibrosis
Conflicting interpretations of pathogenicity
(Sep 27, 2023)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr7:117251751
GRCh38:
Chr7:117611697
LOC111674472, CFTRT1086Snot provided, Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1,
Congenital bilateral aplasia of vas deferens from CFTR mutation, Hereditary pancreatitis, Cystic fibrosis
Uncertain significance
(Jul 15, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr7:117171044
GRCh38:
Chr7:117530990
CFTRY122Cnot specified, Bronchiectasis with or without elevated sweat chloride 1, Hereditary pancreatitis,
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation, Cystic fibrosis
Uncertain significance
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr7:117235045
GRCh38:
Chr7:117594991
CFTRR851Qnot specified, Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis, Hereditary pancreatitis, Cystic fibrosis,
CFTR-related condition, not provided
Uncertain significance
(May 10, 2023)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr7:117175360
GRCh38:
Chr7:117535306
CFTRG213Enot specified, not provided, Bronchiectasis with or without elevated sweat chloride 1,
Hereditary pancreatitis, Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation,
Cystic fibrosis
Uncertain significance
(Jun 8, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination